TrialsgrambetaRCTs are beautiful

AIRTRIP

2016

Anakinra-Treatment of Recurrent Idiopathic Pericarditis

In 21 patients with colchicine-resistant, corticosteroid-dependent recurrent pericarditis, continued anakinra markedly reduced recurrent pericarditis after randomised withdrawal compared with a switch to placebo.

Result

Recurrent pericarditis and time to recurrence after randomisation
Absolute difference
71.8 points
NNT
2

Absolute difference and NNT are derived from the event rates.

Also reported: Transient injection-site reactions in 95.2 %.

Original publication
Subtopic
Recurrent pericarditis
Design
Double-blind randomised-withdrawal RCT after an open-label run-in
Relevance
Supporting: context rather than must-know.
Source
Brucato A, Imazio M, Gattorno M, et al. JAMA. 2016;316(18):1906-1912.doi 10.1001/jama.2016.15826

Discussion & critique

Tiny, single-country, and the randomised-withdrawal design enriches for responders, so the effect size is almost certainly inflated. It was the first randomised proof that interleukin-1 blockade breaks the corticosteroid-dependency cycle.